
Lawrence E. Crane
Examiner (ID: 9019, Phone: (571)272-0651 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1673, 1802, 1609, 1803, 1621, 1211, 1623, 1203 |
| Total Applications | 1975 |
| Issued Applications | 1276 |
| Pending Applications | 96 |
| Abandoned Applications | 610 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4705344
[patent_doc_number] => 20080064868
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-13
[patent_title] => 'Novel Dideoxynucleoside Derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/678973
[patent_app_country] => US
[patent_app_date] => 2007-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10782
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20080064868.pdf
[firstpage_image] =>[orig_patent_app_number] => 11678973
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/678973 | Dideoxynucleoside derivatives | Feb 25, 2007 | Issued |
Array
(
[id] => 5131773
[patent_doc_number] => 20070208170
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-06
[patent_title] => 'INTERMEDIATE AND PROCESS FOR PREPARING OF BETA- ANOMER ENRICHED 21-DEOXY,21,21-DIFLUORO-D-RIBOFURANOSYL NUCLEOSIDES'
[patent_app_type] => utility
[patent_app_number] => 11/678927
[patent_app_country] => US
[patent_app_date] => 2007-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11700
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20070208170.pdf
[firstpage_image] =>[orig_patent_app_number] => 11678927
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/678927 | INTERMEDIATE AND PROCESS FOR PREPARING OF BETA- ANOMER ENRICHED 21-DEOXY,21,21-DIFLUORO-D-RIBOFURANOSYL NUCLEOSIDES | Feb 25, 2007 | Abandoned |
Array
(
[id] => 5423189
[patent_doc_number] => 20090149645
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-11
[patent_title] => 'METHOD FOR DETACHING PROTECTING GROUP ON NUCLEIC ACID'
[patent_app_type] => utility
[patent_app_number] => 12/280764
[patent_app_country] => US
[patent_app_date] => 2007-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19182
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0149/20090149645.pdf
[firstpage_image] =>[orig_patent_app_number] => 12280764
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/280764 | Method for detaching protecting group on nucleic acid | Feb 25, 2007 | Issued |
Array
(
[id] => 5316455
[patent_doc_number] => 20090281053
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-12
[patent_title] => 'NOVEL CRYSTALLINE FORM OF LAMIVUDINE'
[patent_app_type] => utility
[patent_app_number] => 12/297174
[patent_app_country] => US
[patent_app_date] => 2007-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 4737
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20090281053.pdf
[firstpage_image] =>[orig_patent_app_number] => 12297174
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/297174 | Crystalline form of lamivudine | Feb 8, 2007 | Issued |
Array
(
[id] => 92567
[patent_doc_number] => 07732595
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-08
[patent_title] => 'Process for preparing an A2A-adenosine receptor agonist and its polymorphs'
[patent_app_type] => utility
[patent_app_number] => 11/701699
[patent_app_country] => US
[patent_app_date] => 2007-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6455
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/732/07732595.pdf
[firstpage_image] =>[orig_patent_app_number] => 11701699
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/701699 | Process for preparing an A2A-adenosine receptor agonist and its polymorphs | Feb 1, 2007 | Issued |
Array
(
[id] => 5585987
[patent_doc_number] => 20090105189
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-23
[patent_title] => 'METHODS AND COMPOSITIONS FOR AMELIORATING OR INHIBITING DECLINE IN MEMORY OR INTELLIGENCE OR IMPROVING SAME'
[patent_app_type] => utility
[patent_app_number] => 12/162759
[patent_app_country] => US
[patent_app_date] => 2007-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 36021
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 27
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20090105189.pdf
[firstpage_image] =>[orig_patent_app_number] => 12162759
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/162759 | METHODS AND COMPOSITIONS FOR AMELIORATING OR INHIBITING DECLINE IN MEMORY OR INTELLIGENCE OR IMPROVING SAME | Jan 29, 2007 | Abandoned |
Array
(
[id] => 5080479
[patent_doc_number] => 20070123703
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-31
[patent_title] => 'CHLORAL-FREE DCA IN OLIGONUCLEOTIDE SYNTHESIS'
[patent_app_type] => utility
[patent_app_number] => 11/668174
[patent_app_country] => US
[patent_app_date] => 2007-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16847
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20070123703.pdf
[firstpage_image] =>[orig_patent_app_number] => 11668174
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/668174 | Chloral-free DCA in oligonucleotide synthesis | Jan 28, 2007 | Issued |
Array
(
[id] => 5159808
[patent_doc_number] => 20070172852
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-26
[patent_title] => 'Non-destructive Quality Control Methods for Microarrays'
[patent_app_type] => utility
[patent_app_number] => 11/626053
[patent_app_country] => US
[patent_app_date] => 2007-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2095
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0172/20070172852.pdf
[firstpage_image] =>[orig_patent_app_number] => 11626053
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/626053 | Non-destructive Quality Control Methods for Microarrays | Jan 22, 2007 | Abandoned |
Array
(
[id] => 5237160
[patent_doc_number] => 20070129317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-07
[patent_title] => 'Use of boswellic acid and its derivatives for inhibiting normal and increased leucocytic elastase or plasmin activity'
[patent_app_type] => utility
[patent_app_number] => 11/648650
[patent_app_country] => US
[patent_app_date] => 2007-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4665
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20070129317.pdf
[firstpage_image] =>[orig_patent_app_number] => 11648650
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/648650 | Use of boswellic acid and its derivatives for inhibiting normal and increased leucocytic elastase or plasmin activity | Jan 2, 2007 | Abandoned |
Array
(
[id] => 4860626
[patent_doc_number] => 20080269476
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-30
[patent_title] => 'Molecules and methods for nucleic acid sequencing'
[patent_app_type] => utility
[patent_app_number] => 11/643742
[patent_app_country] => US
[patent_app_date] => 2006-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8390
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20080269476.pdf
[firstpage_image] =>[orig_patent_app_number] => 11643742
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/643742 | Molecules and methods for nucleic acid sequencing | Dec 19, 2006 | Abandoned |
Array
(
[id] => 5304130
[patent_doc_number] => 20090298782
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-03
[patent_title] => 'Compounds for Delivering Amino Acids or Peptides with Antioxidant Activity into Mitochondria and Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/097948
[patent_app_country] => US
[patent_app_date] => 2006-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11276
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0298/20090298782.pdf
[firstpage_image] =>[orig_patent_app_number] => 12097948
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/097948 | Compounds for Delivering Amino Acids or Peptides with Antioxidant Activity into Mitochondria and Use Thereof | Dec 17, 2006 | Abandoned |
Array
(
[id] => 4840601
[patent_doc_number] => 20080281087
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-13
[patent_title] => 'Method For Bisulfite Treatment'
[patent_app_type] => utility
[patent_app_number] => 12/095299
[patent_app_country] => US
[patent_app_date] => 2006-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9980
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20080281087.pdf
[firstpage_image] =>[orig_patent_app_number] => 12095299
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/095299 | Method for bisulfite treatment | Dec 11, 2006 | Issued |
Array
(
[id] => 8591957
[patent_doc_number] => 08349834
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-01-08
[patent_title] => 'Dioxolane derivates for the treatment of cancer'
[patent_app_type] => utility
[patent_app_number] => 12/305338
[patent_app_country] => US
[patent_app_date] => 2006-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4799
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12305338
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/305338 | Dioxolane derivates for the treatment of cancer | Dec 6, 2006 | Issued |
Array
(
[id] => 5070199
[patent_doc_number] => 20070191301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-16
[patent_title] => 'Purine derivatives and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/606577
[patent_app_country] => US
[patent_app_date] => 2006-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 16589
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20070191301.pdf
[firstpage_image] =>[orig_patent_app_number] => 11606577
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/606577 | Purine derivatives and methods of use thereof | Nov 29, 2006 | Issued |
Array
(
[id] => 4711715
[patent_doc_number] => 20080300241
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2008-12-04
[patent_title] => 'Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and methods'
[patent_app_type] => utility
[patent_app_number] => 11/601251
[patent_app_country] => US
[patent_app_date] => 2006-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44824
[patent_no_of_claims] => 104
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A9/0300/20080300241.pdf
[firstpage_image] =>[orig_patent_app_number] => 11601251
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/601251 | Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and methods | Nov 16, 2006 | Abandoned |
Array
(
[id] => 4711715
[patent_doc_number] => 20080300241
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2008-12-04
[patent_title] => 'Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and methods'
[patent_app_type] => utility
[patent_app_number] => 11/601251
[patent_app_country] => US
[patent_app_date] => 2006-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44824
[patent_no_of_claims] => 104
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A9/0300/20080300241.pdf
[firstpage_image] =>[orig_patent_app_number] => 11601251
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/601251 | Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and methods | Nov 16, 2006 | Abandoned |
Array
(
[id] => 5189074
[patent_doc_number] => 20070167383
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-19
[patent_title] => 'NUCLEOSIDE COMPOUNDS FOR TREATING VIRAL INFECTIONS'
[patent_app_type] => utility
[patent_app_number] => 11/559475
[patent_app_country] => US
[patent_app_date] => 2006-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19053
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20070167383.pdf
[firstpage_image] =>[orig_patent_app_number] => 11559475
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/559475 | NUCLEOSIDE COMPOUNDS FOR TREATING VIRAL INFECTIONS | Nov 13, 2006 | Abandoned |
Array
(
[id] => 4983436
[patent_doc_number] => 20070087995
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-19
[patent_title] => 'beta-L-2\'-Deoxy-Nucleosides for the Treatment of Hepatitis B'
[patent_app_type] => utility
[patent_app_number] => 11/558288
[patent_app_country] => US
[patent_app_date] => 2006-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 17973
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20070087995.pdf
[firstpage_image] =>[orig_patent_app_number] => 11558288
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/558288 | beta-L-2'-Deoxy-Nucleosides for the Treatment of Hepatitis B | Nov 8, 2006 | Abandoned |
Array
(
[id] => 4487702
[patent_doc_number] => 07884202
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-02-08
[patent_title] => 'Nucleobase having perfluoroalkyl group and process for producing the same'
[patent_app_type] => utility
[patent_app_number] => 12/083780
[patent_app_country] => US
[patent_app_date] => 2006-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23902
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/884/07884202.pdf
[firstpage_image] =>[orig_patent_app_number] => 12083780
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/083780 | Nucleobase having perfluoroalkyl group and process for producing the same | Nov 5, 2006 | Issued |
Array
(
[id] => 5005519
[patent_doc_number] => 20070203090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-30
[patent_title] => 'N-pyrazole A2A receptor agonists'
[patent_app_type] => utility
[patent_app_number] => 11/588834
[patent_app_country] => US
[patent_app_date] => 2006-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 14776
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20070203090.pdf
[firstpage_image] =>[orig_patent_app_number] => 11588834
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/588834 | N-pyrazole A2A receptor agonists | Oct 26, 2006 | Issued |